← Back to headlines
J&J Posts Data for Imaavy Label Expansion in Rare Autoimmune Disease
Johnson & Johnson has released data to support the expansion of Imaavy's label for a rare autoimmune disease linked to anemia, aiming to broaden its therapeutic indications.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
